{
    "root": "3585dbef-6405-e0ff-e063-6394a90a3833",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Losartan Potassium",
    "value": "20250519",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "LOSARTAN POTASSIUM",
            "code": "3ST302B24A"
        }
    ],
    "indications": "losartan potassium tablets angiotensin ii receptor blocker ( arb ) indicated : treatment hypertension , lower blood pressure adults children greater 6 years old . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) reduction risk stroke patients hypertension left ventricular hypertrophy . evidence benefit apply black patients . ( 1.2 ) treatment diabetic nephropathy elevated serum creatinine proteinuria patients type 2 diabetes history hypertension . ( 1.3 )",
    "contraindications": "hypertension usual adult dose : 50 mg daily . ( 2.1 ) usual pediatric starting dose : 0.7 mg per kg daily ( 50 mg ) . ( 2.1 ) hypertensive patients left ventricular hypertrophy usual starting dose : 50 mg daily . ( 2.2 ) add hydrochlorothiazide 12.5 mg and/or increase losartan potassium 100 mg followed increase hydrochlorothiazide 25 mg blood pressure response needed . ( 2.2 , 14.2 ) nephropathy type 2 diabetic patients usual dose : 50 mg daily . ( 2.3 ) increase dose 100 mg daily blood pressure response needed . ( 2.3 )",
    "warningsAndPrecautions": "losartan potassium tablets , usp 50 mg : green light green , oval shaped , biconvex , film coated tablets code `` 145 `` debossed one side `` u `` scored side . bottles 30 : ndc 72162-2507-03 bottles 90 : ndc 72162-2507-09 bottles 1000 : ndc 72162-2507-00 storage store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . keep container tightly closed . protect light . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "hypersensitivity component . ( 4 ) coadministration aliskiren patients diabetes . ( 4 )",
    "indications_original": "Losartan potassium tablets are angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 ) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3 )",
    "contraindications_original": "Hypertension Usual adult dose: 50 mg once daily. ( 2.1 ) Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg). ( 2.1 ) Hypertensive Patients with Left Ventricular Hypertrophy Usual starting dose: 50 mg once daily. ( 2.2 ) Add hydrochlorothiazide 12.5 mg and/or increase losartan Potassium to 100 mg followed by an increase to hydrochlorothiazide 25 mg if further blood pressure response is needed. ( 2.2 , 14.2 ) Nephropathy in Type 2 Diabetic Patients Usual dose: 50 mg once daily. ( 2.3 ) Increase dose to 100 mg once daily if further blood pressure response is needed. ( 2.3 )",
    "warningsAndPrecautions_original": "Losartan potassium tablets, USP 50 mg:\n                  \n                  \n                     Green to light green, oval shaped, biconvex, film coated tablets with code \"145\" debossed on one side and \"U\" and scored on other side.\n                  \n                  \n                  \n                     Bottles of 30: NDC 72162-2507-03\n                  \n                  \n                     Bottles of 90: NDC 72162-2507-09\n                  \n                  \n                     Bottles of 1000: NDC 72162-2507-00\n                  \n                  \n                  \n                  \n                     Storage\n                  \n                  \n                     Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].\n                  \n                  \n                     Keep container tightly closed. Protect from light.\n                  \n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions_original": "Hypersensitivity to any component. ( 4 ) Coadministration with aliskiren in patients with diabetes. ( 4 )"
}